rs140332992
Variant summary
Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP7BS2
This summary comes from the ClinGen Evidence Repository: The p.Arg31= variant in CDKL5 is present in 3 female and 2 male individuals in gnomAD (0.002%) (not sufficient to meet BS1 criteria). The p.Arg31= variant is observed in at least 2 unaffected individuals (internal database) (BS2). The silent p.Arg31= variant is not predicted to affect splicing using multiple computational tools and does not affect a highly conserved nucleotide (BP7). In summary, the p.Arg31= variant in CDKL5 is classified as likely benign based on the ACMG/AMP criteria (BS2, BP7). LINK:https://erepo.genome.network/evrepo/ui/classification/CA171658/MONDO:0100039/016
Frequency
Consequence
NM_001323289.2 synonymous
Scores
Clinical Significance
Conservation
Publications
- CDKL5 disorderInheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
- developmental and epileptic encephalopathy, 2Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
- atypical Rett syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- genetic developmental and epileptic encephalopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- infantile spasmsInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- precocious pubertyInheritance: XL Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CDKL5 | NM_001323289.2 | c.93A>G | p.Arg31Arg | synonymous_variant | Exon 3 of 18 | ENST00000623535.2 | NP_001310218.1 | |
CDKL5 | NM_001037343.2 | c.93A>G | p.Arg31Arg | synonymous_variant | Exon 4 of 22 | NP_001032420.1 | ||
CDKL5 | NM_003159.3 | c.93A>G | p.Arg31Arg | synonymous_variant | Exon 3 of 21 | NP_003150.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000448 AC: 5AN: 111724Hom.: 0 Cov.: 23 show subpopulations
GnomAD2 exomes AF: 0.0000219 AC: 4AN: 182437 AF XY: 0.0000298 show subpopulations
GnomAD4 exome AF: 0.0000237 AC: 25AN: 1057042Hom.: 0 Cov.: 24 AF XY: 0.0000274 AC XY: 9AN XY: 328494 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000447 AC: 5AN: 111779Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 33963 show subpopulations
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:2
- -
CDKL5: BP4, BP7, BS2 -
- -
not specified Uncertain:1
- -
CDKL5 disorder Benign:1
The p.Arg31= variant in CDKL5 is present in 3 female and 2 male individuals in gnomAD (0.002%) (not sufficient to meet BS1 criteria). The p.Arg31= variant is observed in at least 2 unaffected individuals (internal database) (BS2). The silent p.Arg31= variant is not predicted to affect splicing using multiple computational tools and does not affect a highly conserved nucleotide (BP7). In summary, the p.Arg31= variant in CDKL5 is classified as likely benign based on the ACMG/AMP criteria (BS2, BP7). -
History of neurodevelopmental disorder Benign:1
In silico models in agreement (benign);Synonymous alterations with insufficient evidence to classify as benign -
Developmental and epileptic encephalopathy, 2;CN128785:Angelman syndrome-like Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at